Oncotelic enters $178K convertible note financing with Pacific Pier Capital

Oncotelic Therapeutics, Inc.

Issued $178,410 convertible promissory note with 12% OID and 12% interest, maturing in 1 year.
Conversion price: $0.06/share or 85% of lowest VWAP in prior 10 trading days.
Net proceeds to Oncotelic ~$150,000 after buyer's $7,000 legal fee withholding.
Issued 500,000 commitment shares as additional consideration to Pacific Pier.
Prepayment allowed after 6 months; default interest rate of 16% upon event of default.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.